EVAX

EVAX

USD

Evaxion Biotech A/S American Depositary Share

$5.600+0.030 (0.539%)

Real-time Price

Healthcare
Biotechnology
Denmark

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$5.570

High

$6.010

Low

$5.570

Volume

0.09M

Company Fundamentals

Market Cap

44.4M

Industry

Biotechnology

Country

Denmark

Trading Stats

Avg Volume

1.59M

Exchange

NCM

Currency

USD

52-Week Range

Low $1.2Current $5.600High $13.8

Related News

GlobeNewswire

Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate

Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed with our AI-Immunology™ platformEVX-04 is a therapeutic cancer vaccine candidate designed for

View more
Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate
GlobeNewswire

Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

Correcting press release issued under same heading: Date in body text corrected to "November 6, 2025" as in headline. COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a

View more
Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
GlobeNewswire

Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report

View more
Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025